Skip to main content

Table 4 Results of genotyping of PALB2 mutation carriers

From: A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

Proband no.

Marker

position bp

D16S403

22,977,651

D16S481

23,188,290

PALB2

23,554,483*

D16S417

23,717,034

293

Ov. Ca.

2, 3

1, 2

c.509-510delGA

2, 4

375

Ov. Ca.

2, 6

1, 2

c.509-510delGA

2, 4

ZB649

Control

4, 3

1, 2

c.509-510delGA

3, 4

802

Br. Ca.

1, 6

3, 2

c.509-510delGA

2, 4

2076

Br. Ca.

4, 5

1, 1

c.509-510delGA

2, 1

893

Br. Ca.

4, 3

1, 2

c.509-510delGA

3, 4

1540

Br. Ca.

4, 3

1, 1

c.509-510delGA

2, 4

  1. Alleles for each microsatellite marker were numbered according to the size. Ov. Ca. - ovarian cancer patients; Control - a PALB2 mutation carrier from the control group; Br. Ca. - breast cancer patients
  2. * the position of PALB2 gene on chromosome 16 (NCBI reference sequence: NT_010393.16); the position of the deletion is 23,587,357 bp
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us